HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)

Saved in:
Bibliographic Details
Published in:Pathology international 2024-02, Vol.74 (2), p.99-101
Main Authors: Horimoto, Yoshiya, Onagi, Hiroko, Watanabe, Junichiro, Hayashi, Takuo
Format: Article
Language:English
Subjects:
ErbB-2 protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1320-5463
1440-1827
DOI:10.1111/pin.13404